Characteristics of Graves’ Disease in a Cohort of Chronic Hepatitis C Patients Treated With Interferon-alpha and Ribavirin

Huy A Tran, Glenn EM Reeves

Abstract


Background: Thyrotoxicosis resembling Graves’ disease (GD) in association with interferon-alpha therapy in the treatment of chronic hepatitis C is very uncommon, especially after treatment has ceased. Furthermore, it is unknown if this condition behaves differently from GD arising de novo.

Methods: A retrospective analysis was performed to detect and review all cases of GD occurring in our hepatitis C service unit over a five year period including long term outcomes.

Results: There were five cases of GD detected: 3 females and 2 males. These were: 1 case of co-existing GD and a toxic nodule developed during therapy, 2 cases developed GD after therapy and another 2 as part of the tri-phasic thyroiditis. All 5 patients were treated for 6 months with one exception and then followed up for another 12 months.

Conclusions: All patients responded satisfactorily to short term thionamides and remained in long term remission. Although the number is small, this report is a reminder that more cases can be expected as treatment for chronic HCV is likely to increase.




J Endocrinol Metab. 2011;1(1):14-20
doi: https://doi.org/10.4021/jem10w


Keywords


Graves’ disease; Chronic; Hepatitis C; Therapy; Interferon-alpha; Ribavirin; Thionamide

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.             
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.